Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarizotan in Rett Syndrome with Respiratory Symptoms
NCT02790034Phase 3Terminated
- Sponsor
- Newron Pharmaceuticals
- Start
- Oct 2016
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of sarizotan in Rett syndrome (RTT), sponsored by Newron Pharmaceuticals. Started Oct 2016; status: terminated.
02
Drugs
sarizotan
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on NCT02790034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02790034.